APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intranasal Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Intranasal Vaccine Industry Growth and Trends Forecast to 2032

22 December 2025100 pages

Choose your research edition.

Industry ResearchIntranasal Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Intranasal Vaccine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Intranasal Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intranasal Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Intranasal Vaccine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Intranasal Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Intranasal Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Intranasal Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intranasal Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intranasal Vaccine include Abbott, Beijing Wantai Biopharmaceutical Co., Ltd., Sanofi, GlaxoSmithKline, Changchun Baike Company, AstraZeneca, Serum Institute of India, PharmaJet and Crossject and INJEX Pharma GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Intranasal Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Intranasal Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Intranasal Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Intranasal Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Intranasal Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Intranasal Vaccine Market by Company

Abbott

Beijing Wantai Biopharmaceutical Co., Ltd.

Sanofi

GlaxoSmithKline

Changchun Baike Company

AstraZeneca

Serum Institute of India

PharmaJet and Crossject

INJEX Pharma GmbH

BioDiem

Bharat Biotech

Antares Pharma

Intranasal Vaccine Segment by Type

Flu Vaccine

COVID-19 Vaccines

Intranasal Vaccine Segment by Application

Hospital

Clinic

Intranasal Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intranasal Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intranasal Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intranasal Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intranasal Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Intranasal Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Flu Vaccine Table 2. Major Company of COVID-19 Vaccines Table 3. Global Intranasal Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Intranasal Vaccine Sales by Type (2021-2026) & (k units) Table 5. Global Intranasal Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Intranasal Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Intranasal Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Intranasal Vaccine Price by Type (2021-2026) & (US$/unit) Table 9. Global Intranasal Vaccine Sales by Type (2027-2032) & (k units) Table 10. Global Intranasal Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Intranasal Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Intranasal Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Intranasal Vaccine Price by Type (2027-2032) & (US$/unit) Table 14. North America Intranasal Vaccine Sales by Type (2021-2026) & (k units) Table 15. North America Intranasal Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Intranasal Vaccine Sales by Type (2021-2026) & (k units) Table 17. Europe Intranasal Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Intranasal Vaccine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Intranasal Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Intranasal Vaccine Sales by Type (2021-2026) & (k units) Table 21. Latin America Intranasal Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Intranasal Vaccine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Intranasal Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Intranasal Vaccine Industry Trends Table 25. Intranasal Vaccine Industry Drivers Table 26. Intranasal Vaccine Industry Opportunities and Challenges Table 27. Intranasal Vaccine Industry Restraints Table 28. Global Intranasal Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Intranasal Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Intranasal Vaccine Sales by Company (2021-2026) & (k units) Table 31. Global Intranasal Vaccine Sales Share by Company (2021-2026) Table 32. Global Intranasal Vaccine Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Intranasal Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Intranasal Vaccine Major Company Production Sites and Headquarters Table 35. Global Intranasal Vaccine Company, Product Type & Application Table 36. Global Intranasal Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Intranasal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Intranasal Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Intranasal Vaccine Sales by Region (2021-2026) & (k units) Table 41. Global Intranasal Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Intranasal Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Intranasal Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Intranasal Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Intranasal Vaccine Sales by Region (2027-2032) & (k units) Table 46. Global Intranasal Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Intranasal Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Intranasal Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Intranasal Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Intranasal Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Intranasal Vaccine Sales by Application (2021-2026) & (k units) Table 52. Global Intranasal Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Intranasal Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Intranasal Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Intranasal Vaccine Price by Application (2021-2026) & (US$/unit) Table 56. Global Intranasal Vaccine Sales by Application (2027-2032) & (k units) Table 57. Global Intranasal Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Intranasal Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Intranasal Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Intranasal Vaccine Price by Application (2027-2032) & (US$/unit) Table 61. North America Intranasal Vaccine Sales by Application (2021-2026) & (k units) Table 62. North America Intranasal Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Intranasal Vaccine Sales by Application (2021-2026) & (k units) Table 64. Europe Intranasal Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Intranasal Vaccine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Intranasal Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Intranasal Vaccine Sales by Application (2021-2026) & (k units) Table 68. Latin America Intranasal Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Intranasal Vaccine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Intranasal Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Abbott Company Information Table 72. Abbott Business Overview Table 73. Abbott Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Abbott Intranasal Vaccine Product Portfolio Table 75. Abbott Recent Development Table 76. Beijing Wantai Biopharmaceutical Co., Ltd. Company Information Table 77. Beijing Wantai Biopharmaceutical Co., Ltd. Business Overview Table 78. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product Portfolio Table 80. Beijing Wantai Biopharmaceutical Co., Ltd. Recent Development Table 81. Sanofi Company Information Table 82. Sanofi Business Overview Table 83. Sanofi Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Sanofi Intranasal Vaccine Product Portfolio Table 85. Sanofi Recent Development Table 86. GlaxoSmithKline Company Information Table 87. GlaxoSmithKline Business Overview Table 88. GlaxoSmithKline Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. GlaxoSmithKline Intranasal Vaccine Product Portfolio Table 90. GlaxoSmithKline Recent Development Table 91. Changchun Baike Company Company Information Table 92. Changchun Baike Company Business Overview Table 93. Changchun Baike Company Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Changchun Baike Company Intranasal Vaccine Product Portfolio Table 95. Changchun Baike Company Recent Development Table 96. AstraZeneca Company Information Table 97. AstraZeneca Business Overview Table 98. AstraZeneca Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. AstraZeneca Intranasal Vaccine Product Portfolio Table 100. AstraZeneca Recent Development Table 101. Serum Institute of India Company Information Table 102. Serum Institute of India Business Overview Table 103. Serum Institute of India Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Serum Institute of India Intranasal Vaccine Product Portfolio Table 105. Serum Institute of India Recent Development Table 106. PharmaJet and Crossject Company Information Table 107. PharmaJet and Crossject Business Overview Table 108. PharmaJet and Crossject Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. PharmaJet and Crossject Intranasal Vaccine Product Portfolio Table 110. PharmaJet and Crossject Recent Development Table 111. INJEX Pharma GmbH Company Information Table 112. INJEX Pharma GmbH Business Overview Table 113. INJEX Pharma GmbH Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. INJEX Pharma GmbH Intranasal Vaccine Product Portfolio Table 115. INJEX Pharma GmbH Recent Development Table 116. BioDiem Company Information Table 117. BioDiem Business Overview Table 118. BioDiem Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. BioDiem Intranasal Vaccine Product Portfolio Table 120. BioDiem Recent Development Table 121. Bharat Biotech Company Information Table 122. Bharat Biotech Business Overview Table 123. Bharat Biotech Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Bharat Biotech Intranasal Vaccine Product Portfolio Table 125. Bharat Biotech Recent Development Table 126. Antares Pharma Company Information Table 127. Antares Pharma Business Overview Table 128. Antares Pharma Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Antares Pharma Intranasal Vaccine Product Portfolio Table 130. Antares Pharma Recent Development Table 131. North America Intranasal Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. North America Intranasal Vaccine Sales by Country (2021-2026) & (k units) Table 133. North America Intranasal Vaccine Sales Market Share by Country (2021-2026) Table 134. North America Intranasal Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 135. North America Intranasal Vaccine Sales Market Share Forecast by Country (2027-2032) Table 136. North America Intranasal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Intranasal Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Intranasal Vaccine Market Share by Country (2021-2026) Table 139. North America Intranasal Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Intranasal Vaccine Market Share Forecast by Country (2027-2032) Table 141. Europe Intranasal Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Europe Intranasal Vaccine Sales by Country (2021-2026) & (k units) Table 143. Europe Intranasal Vaccine Sales Market Share by Country (2021-2026) Table 144. Europe Intranasal Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 145. Europe Intranasal Vaccine Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Intranasal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Intranasal Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Intranasal Vaccine Market Share by Country (2021-2026) Table 149. Europe Intranasal Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Intranasal Vaccine Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Intranasal Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Intranasal Vaccine Sales by Country (2021-2026) & (k units) Table 153. Asia-Pacific Intranasal Vaccine Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Intranasal Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 155. Asia-Pacific Intranasal Vaccine Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Intranasal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Intranasal Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Intranasal Vaccine Market Share by Country (2021-2026) Table 159. Asia-Pacific Intranasal Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Intranasal Vaccine Market Share Forecast by Country (2027-2032) Table 161. Latin America Intranasal Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Latin America Intranasal Vaccine Sales by Country (2021-2026) & (k units) Table 163. Latin America Intranasal Vaccine Sales Market Share by Country (2021-2026) Table 164. Latin America Intranasal Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 165. Latin America Intranasal Vaccine Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Intranasal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Intranasal Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Intranasal Vaccine Market Share by Country (2021-2026) Table 169. Latin America Intranasal Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Intranasal Vaccine Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Intranasal Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Intranasal Vaccine Sales by Country (2021-2026) & (k units) Table 173. Middle East and Africa Intranasal Vaccine Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Intranasal Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 175. Middle East and Africa Intranasal Vaccine Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Intranasal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Intranasal Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Intranasal Vaccine Market Share by Country (2021-2026) Table 179. Middle East and Africa Intranasal Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Intranasal Vaccine Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Intranasal Vaccine Distributors List Table 184. Intranasal Vaccine Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Intranasal Vaccine Image Figure 2. Global Intranasal Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intranasal Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Intranasal Vaccine Sales (2021-2032) & (k units) Figure 5. Flu Vaccine Image Figure 6. Global Flu Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 7. COVID-19 Vaccines Image Figure 8. Global COVID-19 Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Intranasal Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Intranasal Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Intranasal Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Intranasal Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Intranasal Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Intranasal Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Intranasal Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Intranasal Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Intranasal Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Intranasal Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Intranasal Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Intranasal Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Intranasal Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Intranasal Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Intranasal Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Intranasal Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Intranasal Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Intranasal Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Intranasal Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Intranasal Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Intranasal Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Intranasal Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Intranasal Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Intranasal Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Intranasal Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Intranasal Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Intranasal Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Intranasal Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Intranasal Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Intranasal Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Intranasal Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Intranasal Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Intranasal Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Intranasal Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Intranasal Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Intranasal Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Intranasal Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Intranasal Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Intranasal Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Intranasal Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Intranasal Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Intranasal Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Intranasal Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Intranasal Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Intranasal Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Intranasal Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Intranasal Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Flu Vaccine
  • COVID-19 Vaccines
Applications
  • Hospital
  • Clinic
Companies covered
  • Abbott
  • Beijing Wantai Biopharmaceutical Co., Ltd.
  • Sanofi
  • GlaxoSmithKline
  • Changchun Baike Company
  • AstraZeneca
  • Serum Institute of India
  • PharmaJet and Crossject
  • INJEX Pharma GmbH
  • BioDiem
  • Bharat Biotech
  • Antares Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intranasal Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Intranasal Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Intranasal Vaccine Market by Type
  6. 1.3.1 Flu Vaccine
  7. 1.3.2 COVID-19 Vaccines
  8. 1.4 Global Intranasal Vaccine Market Size by Type
  9. 1.4.1 Global Intranasal Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Intranasal Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Intranasal Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Intranasal Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Intranasal Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Intranasal Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Intranasal Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Intranasal Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Intranasal Vaccine Industry Trends
  2. 2.2 Intranasal Vaccine Industry Drivers
  3. 2.3 Intranasal Vaccine Industry Opportunities and Challenges
  4. 2.4 Intranasal Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Intranasal Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Intranasal Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Intranasal Vaccine Price (2021-2026)
  4. 3.4 Global Intranasal Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intranasal Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Intranasal Vaccine Company, Product Type & Application
  7. 3.7 Global Intranasal Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intranasal Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intranasal Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intranasal Vaccine Tier 1, Tier 2, and Tier 3
4 Intranasal Vaccine Regional Status and Outlook
  1. 4.1 Global Intranasal Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Intranasal Vaccine Historic Market Size by Region
  3. 4.2.1 Global Intranasal Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Intranasal Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Intranasal Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Intranasal Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Intranasal Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Intranasal Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Intranasal Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Intranasal Vaccine by Application
  1. 5.1 Intranasal Vaccine Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Intranasal Vaccine Market Size by Application
  5. 5.2.1 Global Intranasal Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Intranasal Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Intranasal Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Intranasal Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Intranasal Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Intranasal Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Intranasal Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Intranasal Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Intranasal Vaccine Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Beijing Wantai Biopharmaceutical Co., Ltd.
  8. 6.2.1 Beijing Wantai Biopharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Beijing Wantai Biopharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product Portfolio
  12. 6.2.5 Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Intranasal Vaccine Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 GlaxoSmithKline
  20. 6.4.1 GlaxoSmithKline Company Information
  21. 6.4.2 GlaxoSmithKline Business Overview
  22. 6.4.3 GlaxoSmithKline Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline Intranasal Vaccine Product Portfolio
  24. 6.4.5 GlaxoSmithKline Recent Developments
  25. 6.5 Changchun Baike Company
  26. 6.5.1 Changchun Baike Company Company Information
  27. 6.5.2 Changchun Baike Company Business Overview
  28. 6.5.3 Changchun Baike Company Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Changchun Baike Company Intranasal Vaccine Product Portfolio
  30. 6.5.5 Changchun Baike Company Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca Intranasal Vaccine Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 Serum Institute of India
  38. 6.7.1 Serum Institute of India Company Information
  39. 6.7.2 Serum Institute of India Business Overview
  40. 6.7.3 Serum Institute of India Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Serum Institute of India Intranasal Vaccine Product Portfolio
  42. 6.7.5 Serum Institute of India Recent Developments
  43. 6.8 PharmaJet and Crossject
  44. 6.8.1 PharmaJet and Crossject Company Information
  45. 6.8.2 PharmaJet and Crossject Business Overview
  46. 6.8.3 PharmaJet and Crossject Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 PharmaJet and Crossject Intranasal Vaccine Product Portfolio
  48. 6.8.5 PharmaJet and Crossject Recent Developments
  49. 6.9 INJEX Pharma GmbH
  50. 6.9.1 INJEX Pharma GmbH Company Information
  51. 6.9.2 INJEX Pharma GmbH Business Overview
  52. 6.9.3 INJEX Pharma GmbH Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 INJEX Pharma GmbH Intranasal Vaccine Product Portfolio
  54. 6.9.5 INJEX Pharma GmbH Recent Developments
  55. 6.10 BioDiem
  56. 6.10.1 BioDiem Company Information
  57. 6.10.2 BioDiem Business Overview
  58. 6.10.3 BioDiem Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 BioDiem Intranasal Vaccine Product Portfolio
  60. 6.10.5 BioDiem Recent Developments
  61. 6.11 Bharat Biotech
  62. 6.11.1 Bharat Biotech Company Information
  63. 6.11.2 Bharat Biotech Business Overview
  64. 6.11.3 Bharat Biotech Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Bharat Biotech Intranasal Vaccine Product Portfolio
  66. 6.11.5 Bharat Biotech Recent Developments
  67. 6.12 Antares Pharma
  68. 6.12.1 Antares Pharma Company Information
  69. 6.12.2 Antares Pharma Business Overview
  70. 6.12.3 Antares Pharma Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Antares Pharma Intranasal Vaccine Product Portfolio
  72. 6.12.5 Antares Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Intranasal Vaccine Sales by Country
  2. 7.1.1 North America Intranasal Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Intranasal Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Intranasal Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Intranasal Vaccine Market Size by Country
  6. 7.2.1 North America Intranasal Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Intranasal Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Intranasal Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Intranasal Vaccine Sales by Country
  2. 8.1.1 Europe Intranasal Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Intranasal Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Intranasal Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Intranasal Vaccine Market Size by Country
  6. 8.2.1 Europe Intranasal Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Intranasal Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Intranasal Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Intranasal Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Intranasal Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Intranasal Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Intranasal Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Intranasal Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Intranasal Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Intranasal Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Intranasal Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Intranasal Vaccine Sales by Country
  2. 10.1.1 South America Intranasal Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Intranasal Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Intranasal Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Intranasal Vaccine Market Size by Country
  6. 10.2.1 South America Intranasal Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Intranasal Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Intranasal Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Intranasal Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Intranasal Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Intranasal Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Intranasal Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Intranasal Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Intranasal Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Intranasal Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Intranasal Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Intranasal Vaccine Value Chain Analysis
  2. 12.1.1 Intranasal Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Intranasal Vaccine Production Mode & Process
  7. 12.2 Intranasal Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Intranasal Vaccine Distributors
  10. 12.2.3 Intranasal Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst